CompletedPhase 2NCT01816620
Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome
Studying POEMS syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Peking Union Medical College Hospital
- Principal Investigator
- Jian Li, M.D.Peking Union Medical College Hospital
- Intervention
- Lenalidomide, Dexamethasone(drug)
- Enrollment
- 41 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2017
Study locations (1)
- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Collaborators
Celgene Corporation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01816620 on ClinicalTrials.govOther trials for POEMS syndrome
Additional recruiting or active studies for the same condition.